Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis

Modern Rheumatology

Volumn 24, Issue 2, 2014, Pages 331-334

  Huang, Jinxian ^b   Song, Guoxiang ^a   Yin, Zhihua ^b   Luo, Xiuxia ^b   Ye, Zhizhong ^b  

^a SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Dkk 1; MiR 29a

Indexed keywords

C REACTIVE PROTEIN; MICRORNA 29A;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION; HUMAN; MALE; MODIFIED STOKE ANKYLOSING SPONDYLITIS SPINAL SCORE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; OSTEOGENESIS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84905008536     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.854077     Document Type: Article

References (27)

1. Daoussis D , Andonopoulos AP. The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? Semin Arthritis Rheum. 2011 ; 41 (2) : 170-7.
2. Taylan A , Sari I , Akinci B , Bilge S , Kozaci D , Akar S , Et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord. 2012 ; 13 : 191.
3. Kwon SR , Lim MJ , Suh CH , Park SG , Hong YS , Yoon BY , et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int. 2012 ; 32 (8) : 2523-7.
4. Hu Z , Xu M , Li Q , Lin Z , Liao Z , Cao S, et al. Adalimumab significantly reduces inflammation and serum Dkk-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis. Int J Rheum Dis. 2012 ; 15 (4) : 358-65.
5. Daoussis D , Liossis S N, Solomou E E, Tsanaktsi A , Bounia K , Karampetsou M , et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010 ; 62 (1) : 150-8.
6. Heiland G R, Appel H , Poddubnyy D , et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis. 2012 ; 71 (4) : 572-4.
7. Uderhardt S , Diarra D , Katzenbeisser J , David J P, Zwerina J , Richards W , et al. Blockade of Dickkopf (Dkk)-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010 ; 69 (3) : 592-7.
8. Ceribelli A , Yao B , Dominguez-Gutierrez P R, Nahid M A, Satoh M , Chan EK. MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther. 2011 ; 13 (4) : 229.
9. Alevizos I , Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol. 2010 ; 6 (7) : 391-8.
10. Schoolmeesters A , Eklund T , Leake D , Vermeulen A , Smith Q , Force Aldred S , et al. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE. 2009 ; 4 (5) : e5605.
11. Kapinas K , Kessler C , Ricks T , Gronowicz G , Delany AM. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. JBiol Chem. 2010 ; 285 (33) : 25221-31.
12. Arnett FC , Edworthy SM , Bloch DA , McShane DJ , Fries JF , Cooper NS , et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 ; 31 (3) : 315-24.
13. van der Linden S , Valkenburg H A, Cats A.Avaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 ; 27 : 361-8.
14. Livak K J, Schmittgen T D.A nalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 ; 25 : 402-8.
15. R, Einstein S , Ory P , Vosse D , Ni L, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 2008 ; 58 (5) : 1324-31.
16. Diarra D , Stolina M , Polzer K , Zwerina J , Ominsky MS , Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007 ; 13 (2) : 156-63.
17. Li J , Sarosi I , Cattley RC , Pretorius J , Asuncion F , Grisanti M , et al. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone. 2006 ; 39 : 754-66.
18. MacDonald BT , Joiner DM , Oyserman SM , Sharma P , Goldstein SA , He X , et al. Bone mass is inversely proportional to Dkk1 levels in mice. Bone. 2007 ; 41 : 331-9.
19. Morvan F , Boulukos K , Clement-Lacroix P , Roman RS , Suc-Royer I , Vayssiere B , et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. JBone Miner Res. 2006 ; 21 : 934-45.
20. Wang FS , Ko JY , Lin CL , Wu HL , Ke HJ , Tai PJ. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats. Bone. 2007 ; 40 : 485-92.
21. Creemers MC , Franssen MJ , van't Hof MA , Gribnau FW , van de Putte LB , van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005 ; 64 (1) : 127-9.
22. Baraliakos X , Listing J , Rudwaleit M , Sieper J , Braun J.Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change. Arthritis Rheum. 2009 ; 61 (6) : 764-71.
23. Ramiro S , Tubergen A , Stolwijk C , Landewé R , Van De Bosch F , Dougados M , et al. ScorinGradiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?. Arthritis Res Ther. 2013 ; 15 (1) : R14.
24. Dijkmans B , Emery P , Hakala M , Leirisalo-Repo M , Mola EM , Paolozzi L , et al. Etanercept in the longterm treatment of patients with ankylosing spondylitis. JRheumatol. 2009 ; 36 (6) : 1256-64.
25. van der Heijde D , Landewé R , Baraliakos X , Houben H , van Tubergen A , Williamson P , et al. Ankylosing spondylitis study for the evaluation of recombinant infliximab therapy study group. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008 ; 58 (10) : 3063-70.
26. van der Heijde D , Salonen D , Weissman BN , Landewé R , Maksymowych WP , Kupper H , et al. Canadian (M03-606) study group; ATLAS study group. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther. 2009 ; 11 (4) : R127.
27. Poddubnyy D , Rudwaleit M , Haibel H , Listing J , Märker-Hermann E , Zeidler H , Braun J , et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. 2012 ; 71 (10) : 1616-22.